Thermodynamic and structural effects of conformational constraints in protein-ligand interactions. Entropic paradoxy associated with ligand preorganization.

Succinate- and cyclopropane-derived phosphotyrosine (pY) replacements were incorporated into a series of Grb2 SH2 binding ligands wherein the pY+1 residue was varied to determine explicitly how variations in ligand preorganization affect binding energetics and structure. The complexes of these ligands with the Grb2 SH2 domain were examined in a series of thermodynamic and structural investigations using isothermal titration calorimetry and X-ray crystallography. The binding enthalpies for all ligands were favorable, and although binding entropies for all ligands having a hydrophobic residue at the pY+1 site were favorable, binding entropies for those having a hydrophilic residue at this site were unfavorable. Preorganized ligands generally bound with more favorable Gibbs energies than their flexible controls, but this increased affinity was the consequence of relatively more favorable binding enthalpies. Unexpectedly, binding entropies of the constrained ligands were uniformly disfavored relative to their flexible controls, demonstrating that the widely held belief that ligand preorganization should result in an entropic advantage is not necessarily true. Crystallographic studies of complexes of several flexible and constrained ligands having the same amino acid at the pY+1 position revealed extensive similarities, but there were some notable differences. There are a greater number of direct polar contacts in complexes of the constrained ligands that correlate qualitatively with their more favorable binding enthalpies and Gibbs energies. There are more single water-mediated contacts between the domain and the flexible ligand of each pair; although fixing water molecules at a protein-ligand interface is commonly viewed as entropically unfavorable, entropies for forming these complexes are favored relative to those of their constrained counterparts. Crystallographic b-factors in the complexes of constrained ligands are greater than those of their flexible counterparts, an observation that seems inconsistent with our finding that entropies for forming complexes of flexible ligands are relatively more favorable. This systematic study highlights the profound challenges and complexities associated with predicting how structural changes in a ligand will affect enthalpies, entropies, and structure in protein-ligand interactions.

[1]  L. Amzel,et al.  Compensating Enthalpic and Entropic Changes Hinder Binding Affinity Optimization , 2007, Chemical biology & drug design.

[2]  R. Liskamp,et al.  Cyclic phosphopeptides for interference with Grb2 SH2 domain signal transduction prepared by ring-closing metathesis and phosphorylation. , 2003, Organic & biomolecular chemistry.

[3]  P. Bartlett,et al.  Synthesis and Evaluation of Macrocyclic Transition State Analogue Inhibitors for α-Chymotrypsin , 2003 .

[4]  P. Bartlett,et al.  MACROCYCLIC INHIBITORS OF PENICILLOPEPSIN. 1. DESIGN, SYNTHESIS, AND EVALUATION OF AN INHIBITOR BRIDGED BETWEEN P1 AND P3 , 1998 .

[5]  Bernhard Pfeiffer,et al.  Over one hundred peptide-activated G protein-coupled receptors recognize ligands with turn structure. , 2005, Chemical reviews.

[6]  T. Creamer,et al.  Solvation energies of amino acid side chains and backbone in a family of host-guest pentapeptides. , 1996, Biochemistry.

[7]  J. Schlessinger,et al.  Conformation of an Shc-derived phosphotyrosine-containing peptide complexed with the Grb2 SH2 domain , 1997, Journal of biomolecular NMR.

[8]  J. Dunitz The entropic cost of bound water in crystals and biomolecules. , 1994, Science.

[9]  J. Kyte,et al.  The basis of the hydrophobic effect. , 2002, Biophysical chemistry.

[10]  P. Furet,et al.  Structural basis for the high affinity of amino-aromatic SH2 phosphopeptide ligands. , 1998, Journal of molecular biology.

[11]  J. Knowles,et al.  Dehydroquinate synthase: a sheep in wolf's clothing? , 1989 .

[12]  K. Shimamoto,et al.  2-(Carboxycyclopropyl)glycines: binding, neurotoxicity and induction of intracellular free Ca2+ increase. , 1992, European journal of pharmacology.

[13]  G. Bodenhausen,et al.  Thermodynamics of binding of 2-methoxy-3-isopropylpyrazine and 2-methoxy-3-isobutylpyrazine to the major urinary protein. , 2004, Journal of the American Chemical Society.

[14]  S. Martin,et al.  Structural and energetic aspects of Grb2-SH2 domain-swapping. , 2007, Archives of biochemistry and biophysics.

[15]  D. Erdmann,et al.  Structural basis for specificity of GRB2-SH2 revealed by a novel ligand binding mode , 1996, Nature Structural Biology.

[16]  Thomas B. Sundberg,et al.  Design and synthesis of conformationally constrained, extended and reverse turn pseudopeptides as Grb2-SH2 domain antagonists , 2003 .

[17]  B. Roques,et al.  Crystal structures of the SH2 domain of Grb2: highlight on the binding of a new high-affinity inhibitor. , 2002, Journal of molecular biology.

[18]  F. Diederich,et al.  Interactions with aromatic rings in chemical and biological recognition. , 2003, Angewandte Chemie.

[19]  W. DeGrado,et al.  Template-constrained cyclic peptide analogues of somatostatin: subtype-selective binding to somatostatin receptors and antiangiogenic activity. , 2000, Bioorganic & medicinal chemistry.

[20]  P. Kollman,et al.  Solvation Model Based on Weighted Solvent Accessible Surface Area , 2001 .

[21]  J. Ladbury Just add water! The effect of water on the specificity of protein-ligand binding sites and its potential application to drug design. , 1996, Chemistry & biology.

[22]  Dagmar Ringe,et al.  [19]Study of protein dynamics by X-ray diffraction , 1986 .

[23]  Y. Ru,et al.  Azepanone-based inhibitors of human and rat cathepsin K. , 2001, Journal of medicinal chemistry.

[24]  G. Klebe,et al.  Approaches to the description and prediction of the binding affinity of small-molecule ligands to macromolecular receptors. , 2002, Angewandte Chemie.

[25]  Dudley H. Williams,et al.  The free energy change of restricting a bond rotation in the binding of peptide analogues to vancomycin group antibiotics , 1993 .

[26]  J M Sturtevant,et al.  Heat capacity and entropy changes in processes involving proteins. , 1977, Proceedings of the National Academy of Sciences of the United States of America.

[27]  Heather A Carlson,et al.  Exploring experimental sources of multiple protein conformations in structure-based drug design. , 2007, Journal of the American Chemical Society.

[28]  P. Rossky,et al.  Hydration structure of the α-chymotrypsin substrate binding pocket: the impact of constrained geometry , 2000 .

[29]  M. Stone,et al.  NMR relaxation studies of the role of conformational entropy in protein stability and ligand binding. , 2001, Accounts of chemical research.

[30]  H. Chuman,et al.  Prediction of the 1-octanol/H2O partition coefficient, log P, by ab initio MO calculations: hydrogen-bonding effect of organic solutes on log P. , 2002, Analytical sciences : the international journal of the Japan Society for Analytical Chemistry.

[31]  S. Martin,et al.  Synthesis and properties of cyclopropane-derived peptidomimetics. , 2006, Accounts of chemical research.

[32]  Arun K. Ghosh,et al.  Structure-based design: synthesis and biological evaluation of a series of novel cycloamide-derived HIV-1 protease inhibitors. , 2005, Journal of medicinal chemistry.

[33]  Michael Kahn,et al.  29 – DESIGN OF PEPTIDOMIMETICS , 2003 .

[34]  Claudia S Maier,et al.  Changes in structural dynamics of the Grb2 adaptor protein upon binding of phosphotyrosine ligand to its SH2 domain. , 2004, Biochimica et biophysica acta.

[35]  D. G. Udugamasooriya,et al.  Conformational constraint in protein ligand design and the inconsistency of binding entropy. , 2008, Biopolymers.

[36]  L. Kay,et al.  Correlation between binding and dynamics at SH2 domain interfaces , 1998, Nature Structural Biology.

[37]  Mary C. Chervenak,et al.  A Direct Measure of the Contribution of Solvent Reorganization to the Enthalpy of Binding , 1994 .

[38]  Vincenzo Mollica,et al.  Group contributions to the thermodynamic properties of non-ionic organic solutes in dilute aqueous solution , 1981 .

[39]  R. Angeletti,et al.  A transition-state analogue reduces protein dynamics in hypoxanthine-guanine phosphoribosyltransferase. , 2001, Biochemistry.

[40]  R. Anderegg,et al.  MASS SPECTROMETRIC CHARACTERIZATION OF A PROTEIN-LIGAND INTERACTION , 1995 .

[41]  K. P. Murphy,et al.  Evaluation of linked protonation effects in protein binding reactions using isothermal titration calorimetry. , 1996, Biophysical journal.

[42]  D. Cram Preorganization—From Solvents to Spherands , 1986 .

[43]  Stephen Hanessian,et al.  Design and synthesis of conformationally constrained amino acids as versatile scaffolds and peptide mimetics , 1997 .

[44]  Michael K. Gilson,et al.  Theory of free energy and entropy in noncovalent binding. , 2009, Chemical reviews.

[45]  Michael K Gilson,et al.  Host-guest complexes with protein-ligand-like affinities: computational analysis and design. , 2009, Journal of the American Chemical Society.

[46]  H. Fukada,et al.  Enthalpy and heat capacity changes for the proton dissociation of various buffer components in 0.1 M potassium chloride , 1998, Proteins.

[47]  Charles A Laughton,et al.  Strong solute-solute dispersive interactions in a protein-ligand complex. , 2005, Journal of the American Chemical Society.

[48]  S. Martin,et al.  Use of 1,2,3-trisubstituted cyclopropanes as conformationally constrained peptide mimics in SH2 antagonists ☆ , 2000 .

[49]  S. Martin,et al.  Ligand preorganization may be accompanied by entropic penalties in protein-ligand interactions. , 2006, Angewandte Chemie.

[50]  Ronald M. Levy,et al.  The SGB/NP hydration free energy model based on the surface generalized born solvent reaction field and novel nonpolar hydration free energy estimators , 2002, J. Comput. Chem..

[51]  P. Charifson,et al.  Conformational analysis of drug-like molecules bound to proteins: an extensive study of ligand reorganization upon binding. , 2004, Journal of medicinal chemistry.

[52]  C. Hunter,et al.  Quantifying intermolecular interactions: guidelines for the molecular recognition toolbox. , 2004, Angewandte Chemie.

[53]  Reinskje Talhout,et al.  Understanding binding affinity: a combined isothermal titration calorimetry/molecular dynamics study of the binding of a series of hydrophobically modified benzamidinium chloride inhibitors to trypsin. , 2003, Journal of the American Chemical Society.

[54]  Stefan Schmitt,et al.  Do structurally similar ligands bind in a similar fashion? , 2006, Journal of medicinal chemistry.

[55]  Jinfa Ying,et al.  Design, synthesis, and biological evaluation of new cyclic melanotropin peptide analogues selective for the human melanocortin-4 receptor. , 2006, Journal of medicinal chemistry.

[56]  Vladimir N Uversky,et al.  Local Flexibility in Molecular Function Paradigm* , 2006, Molecular & Cellular Proteomics.

[57]  J H Lakey,et al.  Heat does not come in different colours: entropy-enthalpy compensation, free energy windows, quantum confinement, pressure perturbation calorimetry, solvation and the multiple causes of heat capacity effects in biomolecular interactions. , 2001, Biophysical chemistry.

[58]  Richard Wolfenden,et al.  Comparing the polarities of the amino acids: side-chain distribution coefficients between the vapor phase, cyclohexane, 1-octanol, and neutral aqueous solution , 1988 .

[59]  J. Ferreon,et al.  Ligand‐induced changes in dynamics in the RT loop of the C‐terminal SH3 domain of Sem‐5 indicate cooperative conformational coupling , 2003, Protein science : a publication of the Protein Society.

[60]  E. Freire,et al.  Overcoming Roadblocks in Lead Optimization: A Thermodynamic Perspective , 2006, Chemical biology & drug design.

[61]  Shaomeng Wang,et al.  A systematic analysis of the effect of small-molecule binding on protein flexibility of the ligand-binding sites. , 2005, Journal of medicinal chemistry.

[62]  M. Vidal,et al.  Structure-activity relationships of small phosphopeptides, inhibitors of Grb2 SH2 domain, and their prodrugs. , 2004, Journal of medicinal chemistry.

[63]  Stephen R. Johnson,et al.  Molecular properties that influence the oral bioavailability of drug candidates. , 2002, Journal of medicinal chemistry.

[64]  Gabriel Waksman,et al.  Calorimetric and structural studies of 1,2,3-trisubstituted cyclopropanes as conformationally constrained peptide inhibitors of Src SH2 domain binding. , 2002, Journal of the American Chemical Society.

[65]  T. Bhat,et al.  Cyclopropane-derived peptidomimetics. Design, synthesis, evaluation, and structure of novel HIV-1 protease inhibitors. , 1998, Journal of medicinal chemistry.

[66]  C. E. Peishoff,et al.  A critical assessment of docking programs and scoring functions. , 2006, Journal of medicinal chemistry.

[67]  Irene Luque,et al.  Structural parameterization of the binding enthalpy of small ligands , 2002, Proteins.

[68]  Gastone Gilli,et al.  Enthalpy-entropy compensation in drug-receptor binding , 1994 .

[69]  P. Ettmayer,et al.  Structural and conformational requirements for high-affinity binding to the SH2 domain of Grb2(1). , 1999, Journal of medicinal chemistry.

[70]  K. Ogura,et al.  Solution structure of the Grb2 SH2 domain complexed with a high-affinity inhibitor , 2008, Journal of biomolecular NMR.

[71]  M. Snow,et al.  Thermodynamic and structural analysis of phosphotyrosine polypeptide binding to Grb2-SH2. , 1997, Biochemistry.

[72]  T. Chalikian Hydrophobic tendencies of polar groups as a major force in molecular recognition , 2003, Biopolymers.

[73]  P. Bonneau,et al.  Macrocyclic inhibitors of the NS3 protease as potential therapeutic agents of hepatitis C virus infection. , 2003, Angewandte Chemie.

[74]  M. Spaller,et al.  Thermodynamic profiling of conformationally constrained cyclic ligands for the PDZ domain. , 2004, Bioorganic & medicinal chemistry letters.

[75]  M. James,et al.  Lowering the entropic barrier for binding conformationally flexible inhibitors to enzymes. , 1998, Biochemistry.

[76]  S. Homans,et al.  Water, water everywhere--except where it matters? , 2007, Drug discovery today.

[77]  V. Hruby,et al.  De Novo Design, Synthesis, and Biological Activities of High-Affinity and Selective Non-Peptide Agonists of the δ-Opioid Receptor‖ , 1998 .

[78]  Gerhard Klebe,et al.  What Can We Learn from Molecular Recognition in Protein–Ligand Complexes for the Design of New Drugs? , 1996 .

[79]  R. Angeletti,et al.  Immucillin‐H binding to purine nucleoside phosphorylase reduces dynamic solvent exchange , 2000, Protein science : a publication of the Protein Society.

[80]  S. Rosenberg,et al.  1,2,3-trisubstituted cyclopropanes as conformationally restricted peptide isosteres: application to the design and synthesis of novel renin inhibitors. , 1992, Journal of medicinal chemistry.

[81]  Min Zhou,et al.  Understanding noncovalent interactions: ligand binding energy and catalytic efficiency from ligand-induced reductions in motion within receptors and enzymes. , 2004, Angewandte Chemie.

[82]  J. Ladbury Isothermal titration calorimetry: Application to structure-based drug design , 2001 .

[83]  S. Liras,et al.  Cyclopropanes as conformationally restricted peptide isosteres. Design and synthesis of novel collagenase inhibitors , 1993 .

[84]  Qing-xiang Guo,et al.  Isokinetic relationship, isoequilibrium relationship, and enthalpy-entropy compensation. , 2001, Chemical reviews.

[85]  W. G. Hunter,et al.  Statistical interpretation of enthalpy–entropy compensation , 1976, Nature.

[86]  W. Gmeiner,et al.  Hydrogen exchange shows peptide binding stabilizes motions in Hck SH2. , 1999, Biochemistry.

[87]  G. Klebe Virtual ligand screening: strategies, perspectives and limitations , 2006, Drug Discovery Today.

[88]  G. Whitesides,et al.  The paradoxical thermodynamic basis for the interaction of ethylene glycol, glycine, and sarcosine chains with bovine carbonic anhydrase II: an unexpected manifestation of enthalpy/entropy compensation. , 2006, Journal of the American Chemical Society.

[89]  Andrew G. Leach,et al.  Binding affinities of host-guest, protein-ligand, and protein-transition-state complexes. , 2003, Angewandte Chemie.

[90]  T. Schumacher,et al.  Specificity and affinity motifs for Grb2 SH2-ligand interactions , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[91]  H. Schneider,et al.  Stabilities of Hydrogen-Bonded Supramolecular Complexes with Various Numbers of Single Bonds: Attempts To Quantify a Dogma in Host-Guest Chemistry. , 1998, Angewandte Chemie.

[92]  Horst Kessler,et al.  Conformation and Biological Activity of Cyclic Peptides , 1982 .

[93]  Paul A. Bartlett,et al.  Structure-Based Design of an Inhibitor of the Zinc Peptidase Thermolysin , 1994 .

[94]  K. Dill,et al.  A View of the Hydrophobic Effect , 2002 .

[95]  J D Dunitz,et al.  Win some, lose some: enthalpy-entropy compensation in weak intermolecular interactions. , 1995, Chemistry & biology.

[96]  R. S. Spolar,et al.  Hydrophobic effect in protein folding and other noncovalent processes involving proteins. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[97]  P. Furet,et al.  Potent antagonists of the SH2 domain of Grb2: optimization of the X+1 position of 3-amino-Z-Tyr(PO3H2)-X+1-Asn-NH2. , 1998, Journal of medicinal chemistry.

[98]  K. Sharp,et al.  Entropy—enthalpy compensation: Fact or artifact? , 2001, Protein science : a publication of the Protein Society.

[99]  D. Fairlie,et al.  Beta-strand mimetics. , 2004, Chemical reviews.

[100]  R. Panek,et al.  Progress in the development of inhibitors of SH2 domains. , 2000, Current pharmaceutical design.

[101]  J. M. Bradshaw,et al.  Calorimetric investigation of proton linkage by monitoring both the enthalpy and association constant of binding: application to the interaction of the Src SH2 domain with a high-affinity tyrosyl phosphopeptide. , 1998, Biochemistry.

[102]  Paul A. Bartlett,et al.  Macrocyclic Inhibitors of Penicillopepsin. 3. Design, Synthesis, and Evaluation of an Inhibitor Bridged between P2 and P1‘ , 1998 .

[103]  D. Williams,et al.  An enthalpic component in cooperativity: the relationship between enthalpy, entropy, and noncovalent structure in weak associations. , 2001, Journal of the American Chemical Society.

[104]  Gabriel Waksman,et al.  Molecular recognition by SH2 domains. , 2002, Advances in protein chemistry.

[105]  K. Parang,et al.  Conformationally constrained peptide analogues of pTyr-Glu-Glu-Ile as inhibitors of the Src SH2 domain binding. , 2004 .

[106]  Kazuya Machida,et al.  The SH2 domain: versatile signaling module and pharmaceutical target. , 2005, Biochimica et biophysica acta.

[107]  Hans-Jörg Schneider,et al.  Supramolecular Chemistry, Part 85[+] Flexibility, Association Constants, and Salt Effects in Organic Ion Pairs: How Single Bonds Affect Molecular Recognition , 1999 .

[108]  Agnieszka Bronowska,et al.  Global Changes in Local Protein Dynamics Reduce the Entropic Cost of Carbohydrate Binding in the Arabinose-binding Protein , 2007, Journal of molecular biology.

[109]  P. Furet,et al.  Structure-based design of compounds inhibiting Grb2-SH2 mediated protein-protein interactions in signal transduction pathways. , 2000, Current pharmaceutical design.

[110]  J. Onuchic,et al.  Water mediation in protein folding and molecular recognition. , 2006, Annual review of biophysics and biomolecular structure.